Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026

The compiled academic record

Updated November 17, 2026
10,714
citations

indexed for 110 peptides, ranked by the source you should read first.

How we rank

Source pyramid

Meta-analyses lead systematic reviews lead RCTs lead primary studies. Preprints and case reports excluded.

Journal tiers

Five tiers, from NEJM and Lancet down to open-access generalists. About fifty journals are manually tier-weighted.

Trial evidence

Phase and completion status weighting: completed Phase 3 trials outrank earlier-phase or withdrawn entries.

Indexed from PubMed E-utilities, ClinicalTrials.gov v2, and EuropePMC core.

Sort:
01 Semaglutide FDA-Approved · GLP-1 receptor agonist 352trials 95reviews 162studies 02 Tirzepatide FDA-Approved · GIP/GLP-1 dual incretin agonist 226trials 81reviews 139studies 03 Dulaglutide FDA-Approved · GLP-1 receptor agonist 108trials 53reviews 141studies 04 Liraglutide FDA-Approved · GLP-1 receptor agonist 85trials 90reviews 142studies 05 Oxytocin FDA-Approved · Posterior pituitary hormone 92trials 52reviews 178studies 06 Triptorelin FDA-Approved · GnRH agonist (FDA-approved) 108trials 34reviews 113studies 07 Thymosin Alpha-1 Approved in ~30 countries · Thymic peptide; immunomodulator 69trials 51reviews 126studies 08 Orforglipron Phase 3 · Oral non-peptide GLP-1 agonist 74trials 58reviews 63studies 09 NAD+ Observational + Anecdotal · Coenzyme (non-peptide); longevity supplement 20trials 126reviews 128studies 10 Cerebrolysin Approved in 50+ countries · Neurotrophic peptide mixture (porcine brain) 55trials 66reviews 123studies 11 Retatrutide Phase 3 · GIP/GLP-1/glucagon triple agonist 44trials 92reviews 71studies 12 Somatropin (HGH) FDA-Approved · Recombinant human growth hormone 68trials 28reviews 114studies 13 Glutathione Observational + Some RCTs · Endogenous tripeptide antioxidant 27trials 46reviews 197studies 14 Testosterone Cypionate FDA-Approved · Androgen / anabolic steroid (FDA-approved); long-acting testosterone ester 64trials 10reviews 115studies 15 Cagrilintide Phase 2/3 · Long-acting amylin analog 58trials 32reviews 46studies 16 hCG FDA-Approved · Placental glycoprotein hormone (FDA-approved); LH-receptor agonist 22trials 41reviews 172studies 17 Mazdutide Phase 3 (China) · GLP-1/glucagon dual agonist 56trials 26reviews 36studies 18 Survodutide Phase 3 · GLP-1/glucagon dual agonist 45trials 37reviews 41studies 19 LL-37 Preclinical + Animal Studies · Cathelicidin antimicrobial peptide; host-defense 3trials 62reviews 167studies 20 Tesamorelin FDA-Approved · GHRH analog (FDA-approved) 48trials 22reviews 52studies 21 Gonadorelin FDA-Approved · GnRH decapeptide (FDA-approved) 24trials 35reviews 107studies 22 CagriSema Phase 3 · Amylin + GLP-1 combination 40trials 31reviews 37studies 23 Enclomiphene Phase 3 (not approved standalone) · SERM (non-peptide) 37trials 10reviews 105studies 24 SS-31 Phase 3 (not approved) · Mitochondria-targeted tetrapeptide 9trials 40reviews 150studies 25 Hexarelin Phase 2 (not approved) · GHRP; potent ghrelin receptor agonist 30trials 14reviews 113studies 26 Humanin Preclinical + Animal Studies · Mitochondrial-derived peptide (MDP); cytoprotective 1trial 58reviews 119studies 27 GHRP-2 Japan-Approved Diagnostic · GHRP; ghrelin receptor agonist 30trials 15reviews 102studies 28 Follistatin Preclinical + Gene Therapy Trials · Myostatin-binding glycoprotein; anabolic 4trials 27reviews 180studies 29 BPC-157 Anecdotal + Animal Studies · Synthetic pentadecapeptide; cytoprotective 4trials 42reviews 134studies 30 Sermorelin Discontinued (FDA approval 1990; US withdrawal 2008) · GHRH analog 28trials 5reviews 113studies 31 Kisspeptin-10 Phase 2 · Kisspeptin receptor agonist; HPG upstream regulator 10trials 19reviews 161studies 32 PT-141 FDA-Approved · Melanocortin receptor agonist (FDA-approved) 19trials 47reviews 30studies 33 MOTS-C Early Clinical + Animal Studies · Mitochondrial-derived peptide (MDP); metabolic regulator 3trials 36reviews 139studies 34 AICAR Clinical Trials (banned in sport) · AMPK activator nucleoside (non-peptide) 11trials 12reviews 171studies 35 MK-677 Phase 3 (not approved) · Oral non-peptide ghrelin receptor agonist 26trials 17reviews 72studies 36 GHRP-6 Anecdotal + Animal Studies · GHRP; ghrelin receptor agonist 16trials 11reviews 135studies 37 VIP Phase 3 (Aviptadil) / Off-Label · Neuropeptide hormone; multi-organ regulator 10trials 23reviews 122studies 38 Thymalin Russian Clinical + Observational · Thymic peptide extract; immunomodulator 10trials 6reviews 158studies 39 Epitalon Russia-Clinical + Animal Studies · Khavinson pineal tetrapeptide; longevity peptide 6trials 20reviews 126studies 40 Tesofensine Phase 2/3 (mixed) · Triple monoamine reuptake inhibitor (non-peptide) 24trials 15reviews 49studies 41 DSIP Preclinical + Anecdotal · Neuropeptide (sleep-associated) 8trials 9reviews 134studies 42 Melanotan II Anecdotal (Editor-Flagged Unsafe) · Melanocortin receptor agonist (nonselective) 6trials 15reviews 124studies 43 GHK Preclinical + Cosmetic · Matrikine tripeptide; signaling/reparative 2trials 17reviews 138studies 44 Melanotan I FDA/EMA-Approved · MC1R agonist; EU/FDA-approved for EPP 11trials 29reviews 53studies 45 Dermorphin Preclinical + Illicit Use · Opioid peptide (research) 1trial 12reviews 139studies 46 Semax Russia-Approved + Anecdotal · ACTH fragment analog; nootropic 4trials 7reviews 136studies 47 GHK-Cu Cosmetic Clinical + Animal Studies · Matrikine copper-tripeptide 4trials 13reviews 94studies 48 Eloralintide Phase 1/2 · Amylin receptor agonist (investigational) 25trials 4reviews 5studies 49 KPV Preclinical + Anecdotal · Tripeptide; α-MSH-derived anti-inflammatory 0trials 10reviews 97studies 50 ARA-290 Phase 2 · EPO-derived peptide; innate repair receptor (IRR) agonist 8trials 5reviews 55studies 51 MGF Preclinical + Anecdotal · IGF-1 splice variant peptide; anabolic 1trial 16reviews 50studies 52 Ipamorelin Anecdotal + Phase 2 · Growth hormone-releasing peptide (GHRP); ghrelin receptor agonist 5trials 6reviews 50studies 53 Argireline Cosmetic Clinical Studies · Cosmetic peptide; SNAP-25 inhibitor 8trials 2reviews 42studies 54 Selank Russia-Approved + Anecdotal · Tuftsin analog peptide (anxiolytic/nootropic) 3trials 2reviews 63studies 55 Vilon Russian Research · Khavinson short peptide bioregulator 3trials 2reviews 59studies 56 FOXO4-DRI Preclinical · Senolytic peptide 0trials 4reviews 62studies 57 CJC-1295 Anecdotal + Phase 2 (DAC) · GHRH analog (no-DAC or DAC forms) 3trials 10reviews 28studies 58 Follistatin 315 Preclinical · Follistatin isoform; anabolic 1trial 2reviews 40studies 59 SLU-PP-332 Preclinical · ERR agonist small molecule (non-peptide) 0trials 2reviews 36studies 60 Crystagen Russian Research · Khavinson short peptide bioregulator 1trial 1review 33studies 61 TB-500 Anecdotal + Animal Studies · Thymosin β4 fragment; tissue repair 1trial 5reviews 21studies 62 Matrixyl Cosmetic Clinical Studies · Cosmetic signal peptide; collagen stimulator 1trial 1review 29studies 63 IGF-1 LR3 Anecdotal + Animal Studies · IGF-1 analog (extended half-life); anabolic 0trials 0reviews 34studies 64 Rigin Cosmetic Clinical Studies · Cosmetic lipopeptide (anti-inflammatory) 0trials 1review 30studies 65 Pinealon Russian Research · Khavinson short peptide bioregulator 1trial 2reviews 21studies 66 PNC-27 Preclinical · Anticancer peptide (experimental) 0trials 2reviews 25studies 67 Adipotide Preclinical (Editor-Flagged Toxic) · Pro-apoptotic hybrid peptide; experimental 0trials 0reviews 28studies 68 P21 Preclinical · CNTF-derived peptide (neurotrophic mimetic) 0trials 2reviews 19studies 69 IGF-1 DES Anecdotal + Animal Studies · IGF-1 analog (truncated); anabolic 0trials 0reviews 25studies 70 Dihexa Preclinical + Anecdotal · Angiotensin IV analog; HGF potentiator 0trials 4reviews 13studies 71 Follistatin 344 Preclinical · Follistatin isoform; anabolic 0trials 1review 22studies 72 Pal-GHK Cosmetic Clinical Studies · Cosmetic lipopeptide (collagen) 0trials 1review 18studies 73 AOD-9604 Phase 2b (mixed) · hGH fragment; lipolytic 0trials 3reviews 11studies 74 Livagen Russian Research · Khavinson short peptide bioregulator 0trials 0reviews 20studies 75 Decapeptide-12 Cosmetic Clinical Studies · Cosmetic peptide; tyrosinase inhibitor 3trials 0reviews 4studies 76 Syn-Coll Cosmetic Clinical Studies · Cosmetic lipopeptide (collagen) 1trial 1review 10studies 77 5-Amino-1MQ Preclinical + Anecdotal · NNMT inhibitor small molecule 0trials 0reviews 16studies 78 Cardiogen Russian Research · Khavinson short peptide bioregulator 1trial 0reviews 10studies 79 Cortagen Russian Research · Khavinson short peptide bioregulator 0trials 0reviews 15studies 80 Bronchogen Russian Research · Khavinson short peptide bioregulator 0trials 1review 9studies 81 Vesugen Russian Research · Khavinson short peptide bioregulator 0trials 1review 9studies 82 Vialox Cosmetic Clinical Studies · Cosmetic peptide (Botox-like topical) 0trials 0reviews 11studies 83 Pentapeptide-18 Cosmetic Clinical Studies · Cosmetic peptide; enkephalin mimetic 0trials 0reviews 11studies 84 Testagen Russian Research · Khavinson short peptide bioregulator 1trial 1review 3studies 85 PGPIPN Preclinical · Synthetic hexapeptide; immunomodulatory 0trials 0reviews 10studies 86 Nonapeptide-1 Cosmetic Clinical Studies · Cosmetic peptide; MC1R antagonist 1trial 0reviews 5studies 87 Ovagen Russian Research · Khavinson short peptide bioregulator 0trials 0reviews 9studies 88 SNAP-8 Cosmetic Clinical Studies · Cosmetic peptide; SNAP-25 inhibitor 0trials 0reviews 9studies 89 Pancragen Russian Research · Khavinson short peptide bioregulator 0trials 0reviews 8studies 90 AHK-Cu Cosmetic Clinical Studies · Copper tripeptide (cosmetic) 1trial 0reviews 2studies 91 Adamax Anecdotal · Modified Semax analog (nootropic) 0trials 0reviews 6studies 92 Syn-Ake Cosmetic Clinical Studies · Cosmetic peptide (snake-venom inspired) 0trials 0reviews 5studies 93 Prostamax Russian Research · Khavinson peptide bioregulator 0trials 0reviews 5studies 94 CJC-1295 + Ipamorelin Anecdotal + Animal Studies · GHRH analog + selective GHRP blend (GH-secretagogue stack) 0trials 0reviews 5studies 95 Cartalax Russian Research · Khavinson short peptide bioregulator 0trials 1review 1study 96 PE-22-28 Preclinical · Spadin-derived peptide; TREK-1 channel blocker 0trials 0reviews 3studies 97 Chonluten Russian Research · Khavinson short peptide bioregulator 0trials 0reviews 3studies 98 Pal-AHK Cosmetic Clinical Studies · Cosmetic lipopeptide (hair) 0trials 0reviews 2studies 99 PEG-MGF Anecdotal · Pegylated IGF-1 splice variant; anabolic 0trials 0reviews 1study 100 Tripeptide-29 Cosmetic Clinical Studies · Cosmetic tripeptide (collagen) 0trials 0reviews 1study 101 Thymagen Russian Research · Khavinson short peptide bioregulator 0trials 0reviews 1study 102 Vesilute Russian Research · Khavinson short peptide bioregulator 0trials 0reviews 1study 103 Tesamorelin + Ipamorelin FDA-Approved (component) · FDA-approved GHRH analog (Tesamorelin) + selective GHRP (Ipamorelin) blend 0trials 0reviews 0studies 104 Glow Anecdotal · Three-component regenerative blend (matrikine + cytoprotective + actin-regulator) 0trials 0reviews 0studies 105 DS5 No Verified Data · Emerging research peptide 0trials 0reviews 0studies 106 Wolverine Anecdotal · Combination peptide stack 0trials 0reviews 0studies 107 Klow Anecdotal · Four-component regenerative blend (Glow + KPV anti-inflammatory) 0trials 0reviews 0studies 108 Hulk Stack Anecdotal · GH + IGF stack: GHRH analog + selective GHRP + long-acting IGF-1 analog 0trials 0reviews 0studies 109 BPC-157 + KPV Anecdotal + Animal Studies · Cytoprotective pentadecapeptide (BPC-157) + alpha-MSH-derived tripeptide (KPV) blend 0trials 0reviews 0studies 110 Palmitoyl Dipeptide-6 Cosmetic Clinical Studies · Cosmetic lipopeptide (retinol-mimic) 0trials 0reviews 0studies